Literature DB >> 16007674

Adult polyglucosan body disease: a case report of a manifesting heterozygote.

Eroboghene E Ubogu1, Stacey Tay Kiat Hong, Hasan Orhan Akman, Salvatore Dimauro, Bashar Katirji, David C Preston, Barbara E Shapiro.   

Abstract

A 62-year-old man developed progressive gait instability, bladder dysfunction, proximal weakness, distal sensory loss, and mild cognitive impairment over 6 years. Neurologic examination revealed upper and lower motor neuron dysfunction in the lower extremities, with distal sensory loss. Electrodiagnostic studies, magnetic resonance imaging of the brain, and sural nerve biopsy were consistent with adult polyglucosan body disease. Biochemical and genetic analyses demonstrated reduced glycogen brancher enzyme levels associated with a heterozygous point mutation (Tyr329Ser or Y329S) in the glycogen brancher enzyme gene on chromosome 3. Mutational heterozygosity in the glycogen brancher enzyme gene has not been previously reported as a cause for this rare disease. A review of the clinical presentation, pathogenesis, etiology, and diagnosis of this disease is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007674     DOI: 10.1002/mus.20384

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.

Authors:  H Orhan Akman; Tatiana Sheiko; Stacey K H Tay; Milton J Finegold; Salvatore Dimauro; William J Craigen
Journal:  Hum Mol Genet       Date:  2011-08-19       Impact factor: 6.150

2.  Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration.

Authors:  Esther N Bit-Ivan; Kyung-Hwa Lee; Darren Gitelman; Sandra Weintraub; Marsel Mesulam; Rosa Rademakers; Adrian M Isaacs; Kimmo J Hatanpaa; Charles L White; Qinwen Mao; Orhan Akman; Salvatore DiMauro; Eileen H Bigio
Journal:  Neuropathol Appl Neurobiol       Date:  2014-10       Impact factor: 8.090

3.  Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings.

Authors:  Fanny Mochel; Raphael Schiffmann; Marjan E Steenweg; Hasan O Akman; Mary Wallace; Frédéric Sedel; Pascal Laforêt; Richard Levy; J Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L Fogel; Marvin R Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J Moshe Gomori; Marjo S van der Knaap; Alexander Lossos
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

4.  A novel mouse model that recapitulates adult-onset glycogenosis type 4.

Authors:  H Orhan Akman; Valentina Emmanuele; Yasemin Gülcan Kurt; Bülent Kurt; Tatiana Sheiko; Salvatore DiMauro; William J Craigen
Journal:  Hum Mol Genet       Date:  2015-09-18       Impact factor: 6.150

5.  Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.

Authors:  Sing-Chung Li; Chiao-Ming Chen; Jennifer L Goldstein; Jer-Yuarn Wu; Emmanuelle Lemyre; Thomas Andrew Burrow; Peter B Kang; Yuan-Tsong Chen; Deeksha S Bali
Journal:  J Inherit Metab Dis       Date:  2010-01-08       Impact factor: 4.982

6.  Neuromuscular forms of glycogen branching enzyme deficiency.

Authors:  C Bruno; D Cassandrini; S Assereto; H Orhan Akman; C Minetti; S Di Mauro
Journal:  Acta Myol       Date:  2007-07

7.  Genome-environmental risk assessment of cocaine dependence.

Authors:  Changshuai Wei; James C Anthony; Qing Lu
Journal:  Front Genet       Date:  2012-05-18       Impact factor: 4.599

8.  Corpora amylacea mimicking low-grade glioma and manifesting as a seizure: Case report.

Authors:  Seung J Lee; Minsu Kim; Carlito Lagman; Timothy T Bui; William H Yong; Isaac Yang
Journal:  Surg Neurol Int       Date:  2017-04-26

Review 9.  Characterization of cognitive impairment in adult polyglucosan body disease.

Authors:  Paul Theo Zebhauser; Isabell Cordts; Holger Hengel; Bernhard Haslinger; Paul Lingor; Hasan Orhan Akman; Tobias B Haack; Marcus Deschauer
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 6.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.